Latest news with #RajeshKumarPathak
&w=3840&q=100)
Business Standard
4 days ago
- Health
- Business Standard
Centre to aid development of indigenous thrombectomy device for stroke
Technology Development Board to fund S3V Vascular Technologies for manufacturing India's first thrombectomy device, aiming to reduce import dependency and boost stroke care Sanket Koul New Delhi In a push for India's medtech innovation landscape, the Technology Development Board (TDB), under the Centre's Department of Science and Technology (DST), on Friday announced financial support for the development of India's first indigenous thrombectomy device for stroke care. A thrombectomy device is a specialised medical tool used to remove blood clots—also called thrombi—from blood vessels, particularly in the brain, to treat ischaemic strokes. Under the support programme, the TDB will sanction financial assistance to Mysuru-based S3V Vascular Technologies for the establishment of a state-of-the-art upstream integrated manufacturing facility at the Medical Devices Park, Oragadam, in Chennai's Sriperumbudur. Commenting on the development, TDB Secretary Rajesh Kumar Pathak said the project reflects the continued commitment to making India a global hub for affordable, high-end medical technology, especially in areas of critical public health need like stroke care. According to a study recently published in The Lancet Neurology journal, India registered over 1.25 million new stroke cases in 2021, a 51 per cent increase compared to 650,000 cases in 1990. Dr N G Vijaya Gopal, Managing Director of S3V Vascular Technologies, said the company's integrated manufacturing facility will not only reduce dependency on imports of the finished medical devices used in mechanical thrombectomy but also reduce India's reliance on the import of raw materials required for the manufacturing of these complex, life-saving devices. The company stated that it aims to integrate these devices into government reimbursement programmes such as Ayushman Bharat, thereby unlocking a domestic market estimated at $2 billion. 'As part of its outreach, S3V also plans to collaborate with leading hospitals to offer simulator-based training for young interventionalists—especially in Tier-II cities, where the stroke burden is high,' it said. Gopal added that S3V has initiated the CE and USFDA approval process for these devices to expand access to cutting-edge stroke care solutions across India, Asia, Latin America, Europe, and the United States. The company also intends to file patents for critical innovations such as the clot retriever head design, braid-over-coil aspiration catheter structures, and several advanced process technologies.
Hans India
4 days ago
- Health
- Hans India
Govt to aid development of India's 1st indigenous thrombectomy device for stroke care
New Delhi: In a significant boost to India's medtech innovation landscape, the Technology Development Board (TDB), under the Union Department of Science and Technology (DST), on Friday announced financial support to the development of India's first indigenous thrombectomy device for stroke care. The board sanctioned assistance to Mysuru-based S3V Vascular Technologies' pioneering neuro-intervention integrated manufacturing plant for the treatment of stroke, which sees nearly 1.5 million cases every year in the country. The project envisions the establishment of a state-of-the-art upstream integrated manufacturing facility at the Medical Devices Park, Oragadam in Chennai's Sriperumbudur. The plant will develop and manufacture advanced mechanical thrombectomy kits -- a life-saving intervention for patients suffering from acute ischemic stroke due to large vessel occlusion. Compared to conventional thrombolysis, thrombectomy offers significantly improved outcomes, reducing the risk of long-term paralysis and disability. "The TDB is proud to support S3V's vision of building India's first comprehensive neuro-intervention manufacturing ecosystem. This project reflects our continued commitment to making India a global hub for affordable, high-end medical technology -- especially in areas of critical public health needs like stroke care," TDB Secretary Rajesh Kumar Pathak said. "The company's focus on integrating these devices into Ayushman Bharat further aligns with the national goal of inclusive healthcare access," he added. The initiative will help replace expensive imported devices with high-quality, locally manufactured alternatives, enhancing both the affordability and accessibility of stroke care in India. "Our integrated manufacturing facility will not only reduce dependency on imports of the finished medical devices used in Mechanical Thrombectomy but also reduces India's dependency on import of the raw materials used in manufacturing of these critical complex lifesaving medical devices," S3V Vascular Technologies Managing Director, Dr N.G. Vijaya Gopal, said, while lauding the government for its support. Gopal said the company has already initiated the CE and the US FDA approval process for the devices to expand access to cutting-edge stroke care solutions across India, Asia, Latin America, Europe, and the US.
Hans India
24-04-2025
- Health
- Hans India
Centre extends financial aid to indigenous indoor air purification solution
New Delhi: In a significant step toward advancing indigenous clean air technologies, the government on Thursday extending financial support to Gurugram-based Urban Air Labs for their unique project in this field. The financial assistance by Technology Development Board (TDB), under the Department of Science and Technology (DST), is given to the company for their project, titled 'Development & Commercialization of a Made in India Efficient Wall-Mounted Air-Purification System for Indoor Premises.' This intervention marks a commitment to improve the Air Quality Index (AQI) indoors through innovative, plant-based purification systems that remove both particulate and gaseous contaminants. TDB's financial assistance to this promising startup underscores its confidence in the project's potential to deliver sustainable, science-backed air purification solutions. The support aims to promote innovation in climate-responsive technologies while strengthening India's self-reliance under the 'Make in India' and 'Atmanirbhar Bharat' missions, said Ministry of Science and Technology. The core technology harnessed in this product blends natural plant-based filtration with advanced engineering. Based on the 'Urban Munnar Effect' and a patented innovation called 'Breathing Roots', the system enhances the natural air-purifying capacity of leafy indoor plants. Air from the room is pulled toward the plant leaves, then directed into the soil-root zone, where the purification process intensifies. The device features a centrifugal fan that creates suction pressure, allowing the purified air—processed through the roots—to be released in 360 degrees across the indoor space. Fitted within a specially designed planter box, the 'uBreathe Life' system stands out as a compact, aesthetic, and effective wall-mounted solution tailored for homes, offices, hospitals, and other indoor environments. It directly addresses the growing public health concern over poor indoor air quality and represents a game-changing innovation in the field of sustainable air purification. 'TDB's support to Urban Air Labs reflects our mission to back indigenous solutions that address pressing environmental challenges. The fusion of biotechnology and engineering in this project offers a scalable, sustainable way to enhance indoor air quality, aligned with the nation's clean technology goals,' said Rajesh Kumar Pathak, Secretary, TDB.
